Home › Cell Biology › Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Cell Biology JoVE (Open Access) Citable · DOI

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

DOI: 10.3791/56211-v
What you'll learn
  • ✓ Implement remote supervision protocol for home-based tDCS treatment delivery
  • ✓ Conduct baseline assessments and self-administration safety checks
  • ✓ Monitor patient tolerability and adverse events in distributed clinical trials
Protocol

This manuscript provides an updated remote supervision protocol that enables participation in transcranial direct current stimulation (tDCS) clinical trials while receiving treatment sessions from home. The protocol has been successfully piloted in both patients with multiple sclerosis and Parkinson's disease.

Difficulty
advanced
Total time
~45 min per session; variable duration depending on trial length (weeks to months)

Steps

1
Perform baseline clinical assessments pre-treatment

Establish patient eligibility and baseline health status through clinical evaluation before initiating remote-supervised tDCS protocol.

▶ 01:12
2
Train patient on self-administration of tDCS

Instruct patient on proper electrode placement, device operation, and safety procedures to enable independent at-home treatment delivery.

▶ 01:56
3
Conduct remotely supervised tDCS treatment session

Oversee patient-administered stimulation via remote connection, monitoring for adverse events and protocol adherence throughout the session.

▶ 03:49
4
Evaluate protocol feasibility and tolerability outcomes

Assess safety, tolerability, and clinical feasibility data from MS and PD patient cohorts completing remote-supervised tDCS treatment.

▶ 06:25
💬 Comments coming soon